{"text": "@CNBCnow At $4,500 for a round of treatment for remdesivir, Gilead\u2019s new Covid-19 medicine could generate over $2 billion in revenue, even after a promise to give away the first 1.5 million vials https://t.co/2k6es3MboO", "possibly_sensitive": false, "entities": {"urls": [{"start": 196, "end": 219, "url": "https://t.co/2k6es3MboO", "expanded_url": "https://trib.al/Tijd94K", "display_url": "trib.al/Tijd94K"}], "mentions": [{"start": 0, "end": 8, "username": "CNBCnow", "id": "26574283"}]}, "id": "1257343888601251841", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "lang": "en", "in_reply_to_user_id": "26574283", "context_annotations": [{"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "1100410844427350016", "name": "CNBC", "description": "CNBC"}}, {"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "referenced_tweets": [{"type": "replied_to", "id": "1256308139139510272"}], "reply_settings": "everyone", "created_at": "2020-05-04T16:18:38.000Z", "author_id": "1208493639011225600", "conversation_id": "1256308139139510272", "source": "Twitter for Android"}